We are no longer recruiting for the following clinical trials which are active now:

Prothena PRX012-103: Open-Label Extension Study of PRX012 in Subjects with Alzheimer’s Disease Who Were Enrolled in Study PRX012-101 or PRX012-102.

Cognito CA-0011: A Randomized, Double-blind, Sham-controlled, Adaptive- Design Pivotal Study of Sensory Stimulation in Subjects with Alzheimer’s Disease.

Cognito CA-0015 Open Label Extension to a Randomized Double Blind Sham Controlled, Adaptive-Design Pivotal Study of Sensory Stimulation in Subjects with Alzheimer’s Disease.

Eisai BAN2401-G000-301: A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study with an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects with Early Alzheimer’s Disease. Mild Cognitive Impairment MCI to Mild Alzheimer’s Disease.

= Trial is Active No Longer Accepting New Subjects